Drug development is the process of bringing a new medicine to the market once a drug candidate (lead compound) has been identified in drug discovery. Patient engagement in research and drug development is getting more and more important to have real patient centricity.
Presentation at the WECAN Academy 2019:
How therapy development works, the development lifecycle, endpoints, trial design, patient engagement in research
Presenter: Jan Geissler, EUPATI
The following presentation held at the WECAN Academy 2019 will help you to understand:
- How does medicines development work – from Phase I to Phase IV
- Why does patient involvement in clinical research make sense?
- What are the key elements of a clinical trial and trial protocol?